Relationship between Reduced BCL-2 Expression in Circulating Mononuclear Cells and Early Nephropathy in Type 1 Diabetes

Microalbuminuria is the earliest clinical evidence of diabetic nephropathy, but the mechanisms linking hyperglycemia and kidney complications are not clear. The aim of this study was to evaluate whether enhanced oxidative stress in patients with microalbuminuria can contribute to diabetic nephropathy development through downregulation of the antiapoptotic gene Bcl-2 that promotes in turn a pro-inflammatory status. We studied 30 patients with type 1 diabetes (15 with and 15 without microalbuminuria) compared to 15 matched healthy controls. Plasma oxidant status, and expression of Bcl-2, activated NF-kB, inducible Nitric Oxide synthase (iNOS), and monocyte chemoattractant protein (MCP)-1 in circulating monocytes were evaluated at baseline and after 8-week oral vitamin E treatment (600 mg b.i.d.). Bcl-2 expression was significantly reduced in microalbuminuric diabetic patients as a consequence of increased oxidant burden secondary to persistent hyperglycemia. Bcl-2 down-regulation was associated with enhanced expression of NF-kB, iNOS and MCP-1, and showed a strong correlation with the albumin excretion rate. Low Bcl-2 expression and high inflammatory status were normalized by vitamin E both in vivo and in vitro. Our study showed that Bcl-2 down-regulation in diabetic patients with poor glycemic control results in the activation of the NF-kB pathway leading to the development of nephropathy. Vitamin E might provide a novel form of therapy for prevention of nephropathy in diabetic patients in which an acceptable glycemic control is difficult to achieve despite insulin therapy.

[1]  B. Weston,et al.  Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. , 2001, The Biochemical journal.

[2]  O. Pedersen,et al.  Double‐blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[3]  F. Cipollone,et al.  Overexpression of Functionally Coupled Cyclooxygenase-2 and Prostaglandin E Synthase in Symptomatic Atherosclerotic Plaques as a Basis of Prostaglandin E2-Dependent Plaque Instability , 2001, Circulation.

[4]  AndreaMezzetti,et al.  Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary Angioplasty , 2001 .

[5]  M. Reale,et al.  Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[6]  F. Cipollone,et al.  Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm. , 2000, Cardiovascular research.

[7]  F. Cipollone,et al.  Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. , 2000, Diabetes.

[8]  T. Bucciarelli,et al.  Increased systemic oxidative stress after elective endarterectomy: relation to vascular healing and remodeling. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[9]  B. Charpentier,et al.  Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles. , 1999, Blood.

[10]  C. Ferran,et al.  Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-κB , 1999 .

[11]  GiovanniDavì,et al.  In Vivo Formation of 8-Iso-Prostaglandin F2α and Platelet Activation in Diabetes Mellitus , 1999 .

[12]  S. Schiekofer,et al.  Insufficient Glycemic Control Increases Nuclear Factor-κB Binding Activity in Peripheral Blood Mononuclear Cells Isolated From Patients With Type 1 Diabetes , 1998, Diabetes Care.

[13]  U. Maurer,et al.  High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  B. Kasiske,et al.  Central role of the transcription factor nuclear factor-kappa B in mesangial cell production of chemokines. , 1997, Contributions to nephrology.

[15]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[16]  K. Prasad,et al.  Antioxidant defense system in diabetic kidney: a time course study. , 1997, Life sciences.

[17]  S. Grimm,et al.  Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis , 1996, The Journal of cell biology.

[18]  R. Knuechel,et al.  Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. , 1996, The Journal of clinical investigation.

[19]  K. H. Kim,et al.  Role of oxidative stress in the development of diabetic nephropathy. , 1995, Kidney international. Supplement.

[20]  F. Cuccurullo,et al.  Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. , 1995, Atherosclerosis.

[21]  J Ludvigsson,et al.  Declining incidence of nephropathy in insulin-dependent diabetes mellitus. , 1994, The New England journal of medicine.

[22]  John Calvin Reed Bcl-2 and the regulation of programmed cell death , 1994, The Journal of cell biology.

[23]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[24]  M. Becker‐André,et al.  Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). , 1989, Nucleic acids research.

[25]  C. Ferran,et al.  Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. , 1999, The Journal of clinical investigation.

[26]  G. Davı̀,et al.  In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. , 1999, Circulation.

[27]  P. Baeuerle,et al.  Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody. , 1995, Biological chemistry Hoppe-Seyler.

[28]  C. Mogensen,et al.  [Predicting diabetic nephropathy]. , 1984, Journees annuelles de diabetologie de l'Hotel-Dieu.